CNTMF
Price:
$0.07
Market Cap:
$19.32M
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
CNTMF
According to Cansortium Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.00. This represents a change of -184.06% compared to the average of 1.19 of the last 4 quarters.
The mean historical PE Ratio of Cansortium Inc. over the last ten years is -62.17. The current -1.00 PE Ratio has changed 60.84% with respect to the historical average. Over the past ten years (40 quarters), CNTMF's PE Ratio was at its highest in in the December 2021 quarter at 11.25. The PE Ratio was at its lowest in in the June 2018 quarter at -29.56.
Average
-62.17
Median
-6.12
Minimum
-410.70
Maximum
-0.76
Discovering the peaks and valleys of Cansortium Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.58%
Maximum Annual PE Ratio = -0.76
Minimum Annual Increase = -99.62%
Minimum Annual PE Ratio = -410.70
Year | PE Ratio | Change |
---|---|---|
2023 | -1.11 | 46.21% |
2022 | -0.76 | -90.56% |
2021 | -8.06 | 93.24% |
2020 | -4.17 | 168.84% |
2019 | -1.55 | -99.62% |
2018 | -410.70 | 3.58% |
2017 | -11.17 | -81.34% |
The current PE Ratio of Cansortium Inc. (CNTMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.31
5-year avg
-3.13
10-year avg
-62.17
Cansortium Inc.’s PE Ratio is less than TILT Holdings Inc. (-0.03), less than 4Front Ventures Corp. (-0.50), less than Khiron Life Sciences Corp. (-0.20), less than BellRock Brands Inc. (0), greater than Elixinol Wellness Limited (-5.45),
Company | PE Ratio | Market cap |
---|---|---|
-0.03 | $2.36M | |
-0.50 | $17.36M | |
-0.20 | $499.74M | |
0 | $47.84M | |
-5.45 | $1.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cansortium Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cansortium Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cansortium Inc.'s PE Ratio?
How is the PE Ratio calculated for Cansortium Inc. (CNTMF)?
What is the highest PE Ratio for Cansortium Inc. (CNTMF)?
What is the 3-year average PE Ratio for Cansortium Inc. (CNTMF)?
What is the 5-year average PE Ratio for Cansortium Inc. (CNTMF)?
How does the current PE Ratio for Cansortium Inc. (CNTMF) compare to its historical average?